SCHEMBL4254415

SCHEMBL4254415

CCCCN1CCN(c2cc3c(cc2C2=CC(C)(C)CC(C)(C)C2)OCO3)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 3/20 0.38
ADRA1A P35348 3/20 0.38
ADRA1B P35368 3/20 0.38
DRD2 P14416 4/20 0.36
DRD3 P35462 4/20 0.36
HTR1A P08908 2/20 0.36
DRD4 P21917 2/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
SCN9A Q15858 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4249829 0.99 ADRA1D (0.38) ADRA1DADRA1AADRA1BDRD2DRD3
SCHEMBL13806132 0.94 ADRA1D (0.39) ADRA1DADRA1AADRA1BDRD2DRD3
Hydrochloric Acid SCHEMBL4253182 0.93 ADRA1D (0.39) ADRA1DADRA1AADRA1BDRD2DRD3
SCHEMBL14300616 0.84 ADRA1D (0.37) ADRA1DADRA1AADRA1BDRD2DRD3
SCHEMBL13806135 0.83 ADRA1D (0.34) ADRA1DADRA1AADRA1BDRD2DRD3
Hydrochloric Acid SCHEMBL4255106 0.82 ADRA1D (0.34) ADRA1DADRA1AADRA1BDRD2DRD3
SCHEMBL4258520 0.80 ALDH1A1 (0.32) LMNAMEN1CYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL4859577 0.80 DRD2 (0.38) ADRA1AADRA1BDRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL4856467 0.80 MEN1 (0.40) ADRA1AADRA1BDRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL4848434 0.80 DRD2 (0.40) ADRA1DADRA1AADRA1BDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156589-A1 1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-18 US disclosed
US-20090156589-A1 1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-18 US disclosed
US-20090156589-A1 1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-18 US disclosed
US-20060281747-A1 1,2-di(cyclic) substituted benzene derivatives EISAI R&D MANAGEMENT CO., LTD. 2006-12-14 US disclosed
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156589-A1 1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE CCR10, H1-10, VCAM1 ADRA1D 172/4885ADRA1A 324/4885ADRA1B 358/4885
US-20060281747-A1 1,2-di(cyclic) substituted benzene derivatives CCR10, H1-10, CXCL10 ADRA1D 164/4885ADRA1A 254/4885ADRA1B 294/4885
US-20060276465-A1 1,2-di(cyclic) substituted benzene compounds HRH3, CCR10, HRH1 ADRA1D 169/4885ADRA1A 359/4885ADRA1B 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.